IP6 ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
122Superficial siderosis1

122. Superficial siderosis


Clinical trials : 3 Drugs : 3 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04890808
(ClinicalTrials.gov)
May 202312/5/2021Therapeutic Antioxidant SupplementationTherapeutic Antioxidant Supplementation for Enhancement of Neural Protection From Free-iron Toxicity in Superficial SiderosisSuperficial SiderosisDietary Supplement: Inosine;Dietary Supplement: IP6Superficial Siderosis Research Alliance Inc.NULLNot yet recruiting16 Years77 YearsAll50N/ANULL